You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.
Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.
The test adds to the firm's current portfolio of 30 infectious disease and oncology tests that use its Sentosa PCR and NGS workflow.
Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.
The test enables donor screening laboratories to use PCR-based diagnostic technology to screen donated blood and plasma.
Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.
In Nature this week: modified CRISPR approach changes single nucleotides, new salmon genome assembly, and more.
Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.
The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.
It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.
Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.
The UK is implementing COVID-19 testing with a 90-minute turnaround time.
The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.
In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.